1
|
Nicolson M and Fleming JEE (eds): Imaging
and imagining the fetus: The development of obstetric ultrasound.
1st edition. John Hopkins Univeristy Press, Baltimore, 2013.
|
2
|
ACOG Committee on Obstetric Practice. ACOG
practice bulletin. Diagnosis and management of preeclampsia and
eclampsia. Number 33, January 2002. American college of
obstetricians and gynecologists. Int J Gynaecol Obstet. 77:67–75.
2002.PubMed/NCBI
|
3
|
Romero R, Nien JK, Espinoza J, Todem D, Fu
W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, et al: A
longitudinal study of angiogenic (placental growth factor) and
antiangiogenic (soluble endoglin and soluble vascular endothelial
growth factor receptor-1) factors in normal pregnancy and patients
destined to develop preeclampsia and deliver a small for
gestational age neonate. J Matern Fetal Neonatal Med. 21:9–23.
2008.PubMed/NCBI View Article : Google Scholar
|
4
|
Than NG, Romero R, Tarca AL, Kekesi KA, Xu
Y, Xu Z, Juhasz K, Bhatti G, Leavitt RJ, Gelencser Z, et al:
Integrated systems biology approach identifies novel maternal and
placental pathways of preeclampsia. Front Immunol.
9(1661)2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Turco MY, Gardner L, Kay RG, Hamilton RS,
Prater M, Hollinshead MS, McWhinnie A, Esposito L, Fernando R,
Skelton H, et al: Trophoblast organoids as a model for
maternal-fetal interactions during human placentation. Nature.
564:263–267. 2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Redman CW, Sargent IL and Staff AC: IFPA
senior award lecture: Making sense of pre-eclampsia-two placental
causes of preeclampsia? Placenta. 35 (Suppl):S20–S25.
2014.PubMed/NCBI View Article : Google Scholar
|
7
|
Osol G and Bernstein I: Preeclampsia and
maternal cardiovascular disease: Consequence orpredisposition? J
Vasc Res. 51:290–304. 2014.PubMed/NCBI View Article : Google Scholar
|
8
|
Hypertension in pregnancy. Report of the
American college of obstetricians and gynecologists' task force on
hypertension in pregnancy. Obstet Gynecol. 122:1122–1131.
2013.PubMed/NCBI View Article : Google Scholar
|
9
|
McCarthy FP, Adetoba A, Gill C, Bramham K,
Bertolaccini M, Burton GJ, Girardi G, Seed PT, Poston L and
Chappell LC: Urinary congophilia in women with hypertensive
disorders of pregnancy and preexisting proteinuria or hypertension.
Am J Obstet Gynecol. 215:464.e1–e7. 2016.PubMed/NCBI View Article : Google Scholar
|
10
|
Aouache R, Biquard L, Vaiman D and
Miralles F: Oxidative stress in preeclampsia and placental
diseases. Int J Mol Sci. 19(1496)2018.PubMed/NCBI View Article : Google Scholar
|
11
|
Brown MA, Magee LA, Kenny LC, Karumanchi
SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G and Ishaku S:
International Society for the Study of Hypertension in Pregnancy
(ISSHP). The hypertensive disorders of pregnancy: ISSHP
classification, diagnosis & management recommendations for
international practice. Pregnancy Hypertens. 13:291–310.
2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Francisco C, Wright D, Benkő Z, Syngelaki
A and Nicolaides KH: Competing-risks model in screening for
pre-eclampsia in twin pregnancy according to maternal factors and
biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol.
50:589–595. 2017.PubMed/NCBI View Article : Google Scholar
|
13
|
Sammar M, Syngelaki A, Sharabi-Nov A,
Nicolaides K and Meiri H: Can staining of damaged proteins in urine
effectively predict preeclampsia? Fetal Diagn Ther. 41:23–31.
2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Wright D, Syngelaki A, Akolekar R, Poon LC
and Nicolaides K: Competing risks model in screening for
preeclampsia by maternal characteristics and medical history. Am J
Obstet Gynecol. 213:62.e1–62.e10. 2015.PubMed/NCBI View Article : Google Scholar
|
15
|
Poon LC, Shennan A, Hyett JA, Kapur A,
Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P,
McIntyre HD, et al: The international federation of gynecology and
obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide
for first-trimester screening and prevention. Int J Gynaecol
Obstet. 145 (Suppl 1):S1–S33. 2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Webster K, Fishburn S, Maresh M, Findlay
SC and Chappell LC: Guideline Committee. Diagnosis and management
of hypertension in pregnancy: Summary of updated NICE guidance.
BMJ. 366(l5119)2019.PubMed/NCBI View Article : Google Scholar
|
17
|
Buhimschi CS, Norwitz ER, Funai E, Richman
S, Guller S, Lockwood CJ and Buhimschi IA: Urinary angiogenic
factors cluster hypertensive disorders and identify women with
severe preeclampsia. Am J Obstet Gynecol. 192:734–741.
2005.PubMed/NCBI View Article : Google Scholar
|
18
|
Millen KR, Buhimschi CS, Zhao G, Rood KM,
Tabbah S and Buhimschi IA: Serum and urine thioflavin-T-enhanced
fluorescence in severe preeclampsia. Hypertension. 71:1185–1192.
2018.PubMed/NCBI View Article : Google Scholar
|
19
|
Nagarajappa C, Rangappa SS, Suryanarayana
R and Balakrishna S: Urinary congophilia in preeclampsia:
Experience from a rural tertiary-care hospital in India. Pregnancy
Hypertens. 13:83–86. 2018.PubMed/NCBI View Article : Google Scholar
|
20
|
Tong M, Cheng SB, Chen Q, DeSousa J, Stone
PR, James JL, Chamley LW and Sharma S: Aggregated transthyretin is
specifically packaged into placental nano-vesicles in preeclampsia.
Sci Rep. 7(6694)2017.PubMed/NCBI View Article : Google Scholar
|
21
|
Cater JH, Kumita JR, Zeineddine Abdallah
R, Zhao G, Bernardo-Gancedo A, Henry A, Winata W, Chi M, Grenyer
BSF, Townsend ML, et al: Human pregnancy zone protein stabilizes
misfolded proteins including preeclampsia- and
Alzheimer's-associated amyloid beta peptide. Proc Natl Acad Sci
USA. 116:6101–6110. 2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Cheng SB, Nakashima A and Sharma S:
Understanding pre-eclampsia using Alzheimer's etiology: An
intriguing viewpoint. Am J Reprod Immunol. 75:372–381.
2016.PubMed/NCBI View Article : Google Scholar
|
23
|
Olzscha H: Posttranslational modifications
and proteinopathies: How guardians of the proteome are defeated.
Biol Chem. 400:895–915. 2019.PubMed/NCBI View Article : Google Scholar
|
24
|
Balchin D, Hayer-Hartl M and Hartl FU: In
vivo aspects of protein folding and quality control. Science 353,
aac4354, 2016.
|
25
|
Akerfelt M, Morimoto RI and Sistonen L:
Heat shock factors: Integrators of cell stress, development and
lifespan. Nat Rev Mol Cell Biol. 11:545–555. 2010.PubMed/NCBI View
Article : Google Scholar
|
26
|
Uemura E, Niwa T, Minami S, Takemoto K,
Fukuchi S, Machida K, Imataka H, Ueda T, Ota M and Taguchi H:
Large-scale aggregation analysis of eukaryotic proteins reveals an
involvement of intrinsically disordered regions in protein folding.
Sci Rep. 8(678)2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Sweeney P, Park H, Baumann M, Dunlop J,
Frydman J, Kopito R, McCampbell A, Leblanc G, Venkateswaran A,
Nurmi A and Hodgson R: Protein misfolding in neurodegenerative
diseases: Implications and strategies. Transl Neurodegener.
6(6)2017.PubMed/NCBI View Article : Google Scholar
|
28
|
Tanikawa C, Ueda K, Suzuki A, Iida A,
Nakamura R, Atsuta N, Tohnai G, Sobue G, Saichi N, Momozawa Y, et
al: Citrullination of RGG motifs in FET proteins by PAD4 regulates
protein aggregation and ALS susceptibility. Cell Rep. 22:1473–1483.
2018.PubMed/NCBI View Article : Google Scholar
|
29
|
Spurrier J, Shukla AK, McLinden K, Johnson
K and Giniger E: Altered expression of the Cdk5 activator-like
protein, Cdk5α, causes neurodegeneration, in part by accelerating
the rate of aging. Dis Model Mech. 11(dmm031161)2018.PubMed/NCBI View Article : Google Scholar
|
30
|
Vilchez D, Saez I and Dillin A: The role
of protein clearance mechanisms in organismal ageing and
age-related diseases. Nat Commun. 5(5659)2014.PubMed/NCBI View Article : Google Scholar
|
31
|
Wright PE and Dyson HJ: Intrinsically
disordered proteins in cellular signalling and regulation. Nat Rev
Mol Cell Biol. 16:18–29. 2015.PubMed/NCBI View
Article : Google Scholar
|
32
|
Buhimschi IA, Nayeri UA, Zhao G, Shook LL,
Pensalfini A, Funai EF, Bernstein IM, Glabe CG and Buhimschi CS:
Protein misfolding, congophilia, oligomerization, and defective
amyloid processing in preeclampsia. Sci Transl Med.
6(245ra92)2014.PubMed/NCBI View Article : Google Scholar
|
33
|
Puchtler H, Sweat F and Levine M: On the
binding of Congo Red by amyloid. J Histochem Cytochem. 10:355–364.
1962.
|
34
|
Buhimschi IA, Zhao G, Funai EF, Harris N,
Sasson IE, Bernstein IM, Saade GR and Buhimschi CS: Proteomic
profiling of urine identifies specific fragments of SERPINA1 and
albumin as biomarkers of preeclampsia. Am J Obstet Gynecol.
199:551.e1–e16. 2008.PubMed/NCBI View Article : Google Scholar
|
35
|
Rood KM, Buhimschi CS, Dible T, Webster S,
Zhao G, Samuels P and Buhimschi IA: Congo Red Dot Paper Test for
antenatal triage and rapid identification of preeclampsia.
EClinicalMedicine. 8:47–56. 2019.PubMed/NCBI View Article : Google Scholar
|
36
|
Majors CE, Smith CA, Natoli ME, Kundrod KA
and Richards-Kortum R: Point-of-care diagnostics to improve
maternal and neonatal health in low-resource settings. Lab Chip.
17:3351–3387. 2017.PubMed/NCBI View Article : Google Scholar
|
37
|
Buhimschi IA, Buhimschi CS, Tagare H,
Choma M and Jonas S: Methods and compositions for detecting
misfolded proteins. U.S. Patent Number 10, 324, 094 Filed April
10,. 2014, issued June 18, 2019.
|
38
|
Li XM, Liu XM, Xu J, Du J and Cuckle H:
Late pregnancy screening for preeclampsia with a urinary
point-of-care test for misfolded proteins. PLoS One.
15(e0233214)2020.PubMed/NCBI View Article : Google Scholar
|
39
|
Gerasimova EM, Fedotov SA, Kachkin DV,
Vashukova ES, Glotov AS, Chernoff YO and Rubel AA: Protein
misfolding during pregnancy: New approaches to preeclampsia
diagnostics. Int J Mol Sci. 20(6183)2019.PubMed/NCBI View Article : Google Scholar
|
40
|
Bracken H, Buhimschi IA, Rahman A, Smith
PRS, Pervin J, Rouf S, Bousieguez M, López LG, Buhimschi CS,
Easterling T and Winikoff B: Congo red test for identification of
preeclampsia: Results of a prospective diagnostic case-control
study in Bangladesh and Mexico. EClinicalMedicine.
31(100678)2021.PubMed/NCBI View Article : Google Scholar
|